Skip to main content
Figure 2 | Virology Journal

Figure 2

From: Soluble CD40 ligand-activated human peripheral B cells as surrogated antigen presenting cells: A preliminary approach for anti-HBV immunotherapy

Figure 2

Detection of the expression of CD80, CD86, and MHC I and II on sCD40L-activated human B cells as surrogates of APC. (a) The expression of surface molecules MHC-I, MHC-II, CD80, and CD86 on B cells were examined by gating CD19 positive cells by FACS analysis. (b) The expression of MHC-I and MHC-II on B cells was expressed as the mean fluorescence intensity. (c) The expression of CD80 and CD86 on B cells was expressed as the percents in all B cells.

Back to article page

Virology Journal

ISSN: 1743-422X